Stock Stories
Dominating the Weight-Loss Market: Eli Lilly and Novo Nordisk
US-based Eli Lilly and Denmark’s Novo Nordisk dominate the fast-growing global market for weight-loss drugs. The World Health Organisation estimates...
A deep dive into HelloFresh
Netflix’s latest results shocked the market. A growth darling suddenly stopped growing and was shedding subscribers. The stock tumbled ~40%...
Howard Hughes – US property developer that owns both operating property and large tracts of land
Fund manager James McDonald at the Pengana High Conviction Equities Fund provides insight into some of the current opportunities arising...
Immutep – Leading the development of immunotherapy for cancer and autoimmune diseases
Fund manager James McDonald at the Pengana High Conviction Equities Fund provides insight into some of the current opportunities arising...
Stock in Focus: Super Retail Group. It’s all about sustainable after-tax cash earnings.
In recent times, the commentary in our monthly newsletters to our investors has been dominated by a few of the...
Deliveroo. The worst IPO in history – bad timing, bad ESG, or just a bad idea?
Deliveroo has been dubbed London’s ‘worst IPO in history’ after its shares fell 26% in the first day of trading,...
Covid vaccine developer Novavax rises 183% ytd on strong phase 3 results
The star holding for the Fund in 2021 thus far is US vaccine producer Novavax which has risen 183% year...
Priortech – listed on the TASE – 5% holding in the Fund
As highlighted in previous monthly reports, the two sectors that worked well for us in 2020 were the Renewable Energy...
Kamada – dually listed on the Nasdaq and on the TASE (ticker KMDA), 3.5% holding in Fund
We wrote about Kamada in March when the company announced its plans to utilise its Hyper-Immunoglobulin (IgG) Platform Technology to...